𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting progression to Alzheimer's disease in MCI using combined structural atrophy and CSF biomarkers

✍ Scribed by Linda K. McEvoy; Kaj Blennow; James Brewer; Anders Dale; David Heister

Book ID
118467139
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
77 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can CSF biomarkers or pre-treatment prog
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
✍ Γ…. K. Wallin; O. Hansson; K. Blennow; E. Londos; L. Minthon πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

## Abstract ## Objective The main objective of this study was to investigate possible predictors of response to cholinesterase inhibitor (ChEI) treatment, including pre‐treatment progression rates and levels of the cerebrospinal fluid (CSF) biomarkers. A secondary objective was to evaluate whether